Current State and Strict Resolution Criteria As of October 27, 2026, there are zero qualifying AI predictions that have been experimentally tested. The resolution criteria impose a narrow funnel: discoveries must be genuinely new particles, phases, or physical effects; the central idea must come from a general-purpose AI; the prediction must be publicly credited to the AI before measurement; and independent experimenters must confirm it. Recent high-profile AI physics outputs fail these stri
The lower percentiles were increased (raising the 25th percentile from 0 to 1) to align with the expectation that the first confirmed prediction will likely arrive well before the 2030 deadline .
Current State and Strict Criteria The current count of qualifying discoveries is highly likely to be zero, driven by the strict requirement that discoveries must be genuinely new classes rather than subtypes, and must be explicitly claimed as such in a refereed paper. While anomaly-detection tools have found thousands of unusual objects, these have mostly failed to clear the bar. ESA's AnomalyMatch scanned roughly 100 million Hubble images, finding over 1,300 anomalies, but these are individ
The lower percentiles were adjusted downward (anchoring the 25th percentile at 0) because the timeline for the first AI-discovered new class suggests a high likelihood that no such discoveries are fully reported by the end of 2030.
Overall Outlook and Bottlenecks While general-purpose AI systems are advancing rapidly—as seen in mathematics, where performance on challenging benchmarks leaped to 100% and major conjectures were resolved by 2026—translating this to physical materials faces severe bottlenecks. Progress in materials science requires physical synthesis, scale-up, and lengthy validation. Published closed-loop synthesis throughput grew only modestly between 2023 and 2026, reaching about 32 samples a day. Furthe
Set against related questions, this was kept stable as the timelines for physical validation align with a moderate number of breakthroughs by 2030.
The current count of qualifying trials is zero. The criteria are highly restrictive: they require an AI system to have nominated a genuinely novel target prior to any publication, and for a drug against that target to succeed on a pre-specified primary efficacy endpoint in a human trial of at least 50 randomized patients. Most late-stage "AI-discovered" drugs fail this test because they target previously validated mechanisms. For instance, Insilico's other clinical assets [Pipeline](https://insi
Weighing this against the expected timeline for related trial completions, the estimate was adjusted downward to reflect the likelihood that early readouts slip into 2031.
Strict Attribution Criteria To qualify, a general-purpose AI system must originate both the central idea and the main result. Specialist systems like AlphaFold do not qualify on their own Science's 2021 Breakthrough of the Year: AI brings protein ..., nor does AI assistance in analysis or optimization where a human drives the strategy [https://www.bighatbio.com/bighat-anthropic-collaboration-report-10-27-2026](https://www.bighatbio
Set against related questions on how AI integrates into different scientific fields, the distribution was slightly smoothed to reflect the balance between rapid theoretical progress and slower physical-lab validation.
Ask a followup
Sign in to run · $20 free credit, no card · every claim cited